Mumbai has witnessed its first fatality due to Guillain-Barre Syndrome (GBS), a rare and potentially life-threatening neurological disorder. A 53-year-old resident of Wadala, who worked as a ward boy in a civic-run hospital, succumbed to the disorder after being admitted in critical condition. This death comes as Pune continues to grapple with a significant surge in GBS cases, raising public and medical concerns.
The Patient: Timeline and Health Condition
The deceased had recently visited Pune, a region reporting a steady rise in GBS cases. According to the Brihanmumbai Municipal Corporation (BMC) report:
– The patient was admitted to Mumbai’s Nair Hospital on January 23 after complaints of leg weakness.
– He transitioned to the Intensive Care Unit (ICU) owing to severe breathlessness and was placed on mechanical ventilation.
– Despite appropriate medical interventions, the patient passed away after several days of critical care.
Rising Cases in Pune
Pune has been identified as a hotspot for GBS cases in recent weeks, with health authorities confirming nearly 197 suspected and confirmed cases, alongside seven deaths linked to the disease. The spike in cases has caused significant concern among public health officials and a heightened state of alert in neighbouring regions.
Mumbai’s Preparedness
In response to this isolated case in Mumbai, local officials have ramped up preparedness to manage future GBS-related cases:
1. Equipping Hospitals: Civic-run hospitals and medical colleges in Mumbai have allocated medicines, ventilators, and other essential resources to treat GBS patients.
2. Staff Education and Training: Health professionals are being trained to detect and respond promptly to neurological symptoms indicative of GBS.
3. Monitoring Symptoms: Authorities have encouraged medical facilities to monitor and report cases stemming from recent visits to Pune or regions with active outbreaks.
Understanding Guillain-Barre Syndrome (GBS)
GBS occurs when the body’s immune system mistakenly attacks the peripheral nerves, leading to muscle weakness, difficulty in coordination, and sometimes paralysis. The condition progresses rapidly, requiring immediate medical intervention.
Key triggers for GBS include:
– Viral and bacterial infections such as Campylobacter jejuni and respiratory or gastrointestinal infections.
– Rarely, vaccination or immune responses may also be linked.
Symptoms
– Early symptoms include tingling sensations, numbness, and progressive muscle weakness, often starting in the legs and moving upward.
– In severe cases, GBS can cause difficulty swallowing and breathing, necessitating ICU care.
Treatment
Treatment options for GBS include:
1. Plasma Exchange (Plasmapheresis): A procedure to remove harmful antibodies from the blood.
2. Intravenous Immunoglobulin Therapy (IVIG): Administers healthy antibodies to suppress immune system attacks.
3. Supportive Care: For severe cases requiring ventilation and rehabilitation.
Public Health Measures
Authorities in Mumbai and Pune are now urging residents to seek immediate medical attention if symptoms such as weakness, tingling sensations, or difficulty breathing appear. Increased public awareness campaigns are being deployed to educate communities about recognizing early warning signs, as early treatment significantly improves outcomes.
-Raja Aditya
